XML 63 R42.htm IDEA: XBRL DOCUMENT v3.24.1
Shareholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2023
Shareholders’ Equity [Abstract]  
Schedule of Awards Granted During the years ended December 31, 2023, and December 2022, the following awards were granted:
Award Type (2015 Plan)  Number of
Awards in
2023		   Number of
Awards in
2022 (*)		   Vesting Conditions  Expiration Date
Options   400    16,778   Over 4 years from grant date-25% every year (from the second year- 2.08% each month)  10th anniversary of Grant Date
RSU   45,100    59,200   Over 3 years from grant date   
*Adjusted to reflect reverse stock split, see note 2(ff).
Schedule of Share Option Activity Under Option Plans A summary of the Company’s share option activity under option plans is as follows:
   Number of
Options		   Weighted-
Average
Exercise
Price		   Weighted
Average
Remaining
Contractual
Life		 
Outstanding – January 1, 2023   96,459   $4.89    5.34 
Granted   400   $1.48    9.71 
Exercised   (2,489)  $0.90      
Forfeited   (6,606)  $22.74      
                
Outstanding – December 31, 2023   87,764   $3.63    4.11 
                
Exercisable – December 31, 2023   80,064   $2.36    3.67 
   Number of
Options (*)		   Weighted-
Average
Exercise
Price (*)		   Weighted
Average
Remaining
Contractual
Life		 
Outstanding – January 1, 2022   89,049   $1.52    5.43 
Granted   16,778   $21.96      
Exercised   (7,775)  $0.81      
Forfeited   (1,593)  $15.09      
                
Outstanding – December 31, 2022   96,459   $4.89    5.34 
                
Exercisable – December 31, 2022   77,196   $1.48    4.36 
*Adjusted to reflect reverse stock split, see note 2(ff).
Schedule of Ordinary Shares Issuable upon Outstanding Options and Exercisable Options The following table summarize information as of December 31, 2023, regarding the number of ordinary shares issuable upon outstanding options and exercisable options:
Exercise price  Options
outstanding as of
December 31,
2023		   Weighted
average
remaining
contractual
life (years)		   Options
exercisable as of
December 31,
2023		   Weighted
average
remaining
contractual
life (years)		 
0.64   30,309    1.61    30,309    1.61 
1.06   43,461    4.44    43,402    4.43 
1.48   400    9.71    100    9.71 
5.78   5,500    8.96    1,750    8.96 
13.62   3,894    7.41    2,524    7.41 
40.00   4,200    8.72    1,979    8.72 
    87,764         80,064      
Exercise price  Options
outstanding as of
December 31,
2022 (*)		   Weighted
average
remaining
contractual
life (years)		   Options
exercisable as of
December 31,
2022		   Weighted
average
remaining
contractual
life (years)		 
0.64   31,236    2.61    31,236    2.61 
1.06   44,989    5.43    43,752    5.39 
5.78   8,843    9.96    
-
    
-
 
13.62   3,891    8.41    1,547    8.41 
40.00   7,500    9.72    661    9.72 
    96,459         77,196      
*Adjusted to reflect reverse stock split, see note 2(ff).
Schedule of Fair Value of the Share Options Granted

Key assumptions used to estimate the fair value of the share options granted during the year ended December 31, 2022 included:

     
   2022 
Expected term of options (years)   10 
Expected common stock price volatility**   
54
%
Expected dividend rate   0%
Risk-free interest rate   3.21%-3.25%
** The expected volatility was based on the historical stock prices of publicly traded comparable companies.

 
Schedule of Share-Based Compensation Expense for Share Options Share-based compensation expense for share options in the consolidated statements of comprehensive loss is summarized as follows:
   Year Ended
December 31,		 
   2023   2022 
Cost of revenues   3    3 
Research and development   23    26 
Sales and marketing   11    11 
General and administrative   11    12 
Total Share-based compensation expense   48    52 
Share-based compensation expense for RSUs in the consolidated statement of comprehensive loss is summarized as follows:
   Year Ended
December 31		 
   2023   2022 
   U.S. dollars in thousands 
Cost of revenues   9    3 
Research and development   53    18 
Sales and marketing   47    12 
General and administrative   220    135 
Total Share-based compensation expense   329    168 
Schedule of RSUs Activity under Option Plans A summary of the Company’s RSUs activity under option plans is as follows:
   Year ended
December 31, 2023		   Year ended
December 31, 2022		 
   Number of
RSUs		   Weighted-
Average Grant
Date Fair Value		   Number of
RSUs (*)		   Weighted-
Average Grant
Date Fair Value		 
RSUs outstanding at the beginning of the year   59,200   $16.20    
-
    
-
 
Granted during the year   43,100   $3.33    59,200   $16.20 
Vested during the year   (29,520)   12.36    
-
    
-
 
Forfeited during the year   (1,500)   16.20    
-
    
-
 
Outstanding at the end of the year   71,280   $10.35    59,200   $16.20 
*Adjusted to reflect reverse stock split, see note 2(ff).